Clinical Trials Browser

Completed × INDUSTRY × enzalutamide × Clear all

Parkinson Disease 4, Autosomal Dominant Lewy Body

Biochemically Recurrent Prostate Cancer

Prostatic Neoplasms, Castration-Resistant

Neoplasm Metastasis, Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Metastatic Hormone Sensitive Prostate Cancer

Prostatic Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body

Breast Neoplasms

Prostatic Neoplasms

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

Metastatic Castration Resistant Prostate Cancer

Prostatic Neoplasms, Castration-Resistant

Prostatic Neoplasms, Castration-Resistant

Non-metastatic Castration-resistant Prostate Cancer

Prostatic Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

Neoplasm Metastasis, Prostatic Neoplasms

Metastatic Castration Resistant Prostate Cancer

Breast Neoplasms

Metastatic Castration Resistant Prostate Cancer

Breast Neoplasms

Prostatic Neoplasms

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

Prostatic Neoplasms

Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Castration-resistant Prostate Cancer

Metastatic Castration Resistant Prostate Cancer

Prostatic Neoplasms

Metastatic Castration Resistant Prostate Cancer

Prostatic Neoplasms

Prostatic Neoplasms, Castration-Resistant

Prostatic Neoplasms, Castration-Resistant

Non-metastatic Prostate Cancer

Non-metastatic Castration-resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

Prostatic Neoplasms

Prostatic Neoplasms

Metastatic Castration Resistant Prostate Cancer

Clinical Trials

KEYNOTE-991

ARAMON

A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

PROSPER

CheckMate 9KD

A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan

A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)

ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer

An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants

ARCHES

ARROW

KEYNOTE-991

Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely

Study to Evaluate CCS1477 in Advanced Tumours

TRITON3

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)

DEAR-EXT

A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces

KEYLYNK-010

PRESIDE

A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy

A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer

A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate Cancer

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients

Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer

A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

A Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100

UPWARD

A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer

ENACT

A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients

A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Long-Term Specified Drug Use-Results Survey for Xtandi Capsule

A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden

A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer

A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics

PREMISE

Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)

IMbassador250

ARENA

DEAR

Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)

PLATO

Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients

RAMP